Online Family Support and Education for Schizophrenia

The recruitment status of this study is unknown because the information has not been verified recently.
Verified December 2005 by National Institute of Mental Health (NIMH).
Recruitment status was  Active, not recruiting
Sponsor:
Information provided by:
National Institute of Mental Health (NIMH)
ClinicalTrials.gov Identifier:
NCT00046085
First received: September 19, 2002
Last updated: October 5, 2010
Last verified: December 2005
  Purpose

This study will evaluate the benefits of providing families of schizophrenia patients the opportunity to interact with each other using the Internet.


Condition Intervention
Schizophrenia
Behavioral: Family Psychoeducational Program
Behavioral: Customary care

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Treatment
Official Title: Online Family Support and Education for Schizophrenia

Resource links provided by NLM:


Further study details as provided by National Institute of Mental Health (NIMH):

Estimated Enrollment: 72
Study Start Date: March 2001
Arms Assigned Interventions
Active Comparator: 1
18 months of customary care
Behavioral: Customary care
Participants will receive care as usual.
Experimental: 2
18 months of customary care with access to the educational website for the first year
Behavioral: Family Psychoeducational Program
Families are provided with private, secure access to the website, which features family-to-family chat capabilities, video lectures on the management of schizophrenia, written materials on important issues in schizophrenia management, professionally facilitated online discussions of the material, and additional resource links.
Behavioral: Customary care
Participants will receive care as usual.

Detailed Description:

Although psychoeducational programs for schizophrenia can reduce patient relapse rates and reduce family distress, participation rates are often low. This study will provide the families of schizophrenia patients with knowledge of illness management to reduce family burden and increase perceived social support.

Relatives of patients with schizophrenia receive either 18 months of customary care or 18 months of customary care with access to the educational website for the first year. Families are provided with private, secure access to the website, which features family-to-family chat capabilities, video lectures on the management of schizophrenia, written materials on important issues in schizophrenia management, professionally facilitated online discussions of the material, and additional resource links.

Relatives have 90-minute interviews at the beginning of the project and every 6 months for 18 months. The interviews are used to assess the family member's perception of the patient's symptoms, his or her knowledge of the illness, the illness's impact on the family member, and his or her perception of the website intervention.

Patients with schizophrenia or schizoaffective disorder are also asked to complete interviews and assessments at the beginning of the project and every 3 months for 18 months. The assessments include questions about symptoms, medication compliance and side effects, hospitalizations, and social functioning.

  Eligibility

Ages Eligible for Study:   18 Years to 60 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria for Patients:

  • DSM-IV diagnosis of schizophrenia or schizoaffective disorder
  • Stable antipsychotic medication regimen for at least 1 month
  • Able to come to the West Los Angeles area for assessments

Inclusion Criteria for Relatives:

  • At least 4 hours of weekly contact with patient
  • Access to a computer and Internet connection; expect to stay online for the next 12 months
  • Able to come to the West Los Angeles area for assessments
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00046085

Locations
United States, California
VA Greater Los Angeles Healthcare System
Los Angeles, California, United States, 90073
Sponsors and Collaborators
  More Information

No publications provided

Responsible Party: Shirley M Glynn, PhD, VA Greater Los Angeles Healthcare System
ClinicalTrials.gov Identifier: NCT00046085     History of Changes
Other Study ID Numbers: R21 MH62135, DSIR AT-SP
Study First Received: September 19, 2002
Last Updated: October 5, 2010
Health Authority: United States: Federal Government

Keywords provided by National Institute of Mental Health (NIMH):
Schizoaffective disorder
Diagnosis, Dual (Psychiatry)
Psychoeducation
Internet

Additional relevant MeSH terms:
Schizophrenia
Schizophrenia and Disorders with Psychotic Features
Mental Disorders

ClinicalTrials.gov processed this record on July 23, 2014